Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques

Mian er Cong, Ae S. Youngpairoj, Wutyi Aung, Sunita Sharma, James Mitchell, Charles Dobard, Walid Heneine, J. Gerardo Garcia-Lerma

Research output: Contribution to journalArticle

Abstract

Transmission of drug-resistant HIV has been widely documented. We generated tenofovir (TFV)- and emtricitabine (FTC)-resistant SHIV162P3 mutants that can be used to investigate the transmission efficiency of drug-resistant viruses and their impact on the efficacy of pre-exposure prophylaxis. Both SHIV162p3 M184V and SHIV162p3 K65R replicated in vitro at high titers. Drug resistance profiles were similar to those seen in HIV. Virus infectivity to virion particle ratios were 4- and 10-fold lower in SHIV162p3 M184V and SHIV162p3 K65R, compared to a concurrently generated WT SHIV162p3, respectively. Mucosal transmissibility studies using a repeat low-dose macaque model of rectal and vaginal transmission showed that both mutants were able to efficiently infect macaques only after the dose was increased to adjust for fitness reductions due to K65R and M184V. Our results in limited number of macaques suggest that the reduction in fitness due to M184V and K65R decreases virus transmissibility, and identify in vitro infectivity parameters that associate with mucosal transmissibility.

Original languageEnglish (US)
Pages (from-to)435-440
Number of pages6
JournalVirology
Volume412
Issue number2
DOIs
StatePublished - Apr 10 2011
Externally publishedYes

Fingerprint

Tenofovir
Macaca
Viruses
HIV
Drug Resistance
Pharmaceutical Preparations
Virion
Emtricitabine

Keywords

  • HIV-1 drug resistance
  • Mucosal transmissibility
  • Pre-exposure prophylaxis

ASJC Scopus subject areas

  • Virology

Cite this

Cong, M. E., Youngpairoj, A. S., Aung, W., Sharma, S., Mitchell, J., Dobard, C., ... Garcia-Lerma, J. G. (2011). Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques. Virology, 412(2), 435-440. https://doi.org/10.1016/j.virol.2011.01.038

Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques. / Cong, Mian er; Youngpairoj, Ae S.; Aung, Wutyi; Sharma, Sunita; Mitchell, James; Dobard, Charles; Heneine, Walid; Garcia-Lerma, J. Gerardo.

In: Virology, Vol. 412, No. 2, 10.04.2011, p. 435-440.

Research output: Contribution to journalArticle

Cong, ME, Youngpairoj, AS, Aung, W, Sharma, S, Mitchell, J, Dobard, C, Heneine, W & Garcia-Lerma, JG 2011, 'Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques', Virology, vol. 412, no. 2, pp. 435-440. https://doi.org/10.1016/j.virol.2011.01.038
Cong, Mian er ; Youngpairoj, Ae S. ; Aung, Wutyi ; Sharma, Sunita ; Mitchell, James ; Dobard, Charles ; Heneine, Walid ; Garcia-Lerma, J. Gerardo. / Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques. In: Virology. 2011 ; Vol. 412, No. 2. pp. 435-440.
@article{25c3f583a4244f2fa5e844bef8dbc3e9,
title = "Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques",
abstract = "Transmission of drug-resistant HIV has been widely documented. We generated tenofovir (TFV)- and emtricitabine (FTC)-resistant SHIV162P3 mutants that can be used to investigate the transmission efficiency of drug-resistant viruses and their impact on the efficacy of pre-exposure prophylaxis. Both SHIV162p3 M184V and SHIV162p3 K65R replicated in vitro at high titers. Drug resistance profiles were similar to those seen in HIV. Virus infectivity to virion particle ratios were 4- and 10-fold lower in SHIV162p3 M184V and SHIV162p3 K65R, compared to a concurrently generated WT SHIV162p3, respectively. Mucosal transmissibility studies using a repeat low-dose macaque model of rectal and vaginal transmission showed that both mutants were able to efficiently infect macaques only after the dose was increased to adjust for fitness reductions due to K65R and M184V. Our results in limited number of macaques suggest that the reduction in fitness due to M184V and K65R decreases virus transmissibility, and identify in vitro infectivity parameters that associate with mucosal transmissibility.",
keywords = "HIV-1 drug resistance, Mucosal transmissibility, Pre-exposure prophylaxis",
author = "Cong, {Mian er} and Youngpairoj, {Ae S.} and Wutyi Aung and Sunita Sharma and James Mitchell and Charles Dobard and Walid Heneine and Garcia-Lerma, {J. Gerardo}",
year = "2011",
month = "4",
day = "10",
doi = "10.1016/j.virol.2011.01.038",
language = "English (US)",
volume = "412",
pages = "435--440",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques

AU - Cong, Mian er

AU - Youngpairoj, Ae S.

AU - Aung, Wutyi

AU - Sharma, Sunita

AU - Mitchell, James

AU - Dobard, Charles

AU - Heneine, Walid

AU - Garcia-Lerma, J. Gerardo

PY - 2011/4/10

Y1 - 2011/4/10

N2 - Transmission of drug-resistant HIV has been widely documented. We generated tenofovir (TFV)- and emtricitabine (FTC)-resistant SHIV162P3 mutants that can be used to investigate the transmission efficiency of drug-resistant viruses and their impact on the efficacy of pre-exposure prophylaxis. Both SHIV162p3 M184V and SHIV162p3 K65R replicated in vitro at high titers. Drug resistance profiles were similar to those seen in HIV. Virus infectivity to virion particle ratios were 4- and 10-fold lower in SHIV162p3 M184V and SHIV162p3 K65R, compared to a concurrently generated WT SHIV162p3, respectively. Mucosal transmissibility studies using a repeat low-dose macaque model of rectal and vaginal transmission showed that both mutants were able to efficiently infect macaques only after the dose was increased to adjust for fitness reductions due to K65R and M184V. Our results in limited number of macaques suggest that the reduction in fitness due to M184V and K65R decreases virus transmissibility, and identify in vitro infectivity parameters that associate with mucosal transmissibility.

AB - Transmission of drug-resistant HIV has been widely documented. We generated tenofovir (TFV)- and emtricitabine (FTC)-resistant SHIV162P3 mutants that can be used to investigate the transmission efficiency of drug-resistant viruses and their impact on the efficacy of pre-exposure prophylaxis. Both SHIV162p3 M184V and SHIV162p3 K65R replicated in vitro at high titers. Drug resistance profiles were similar to those seen in HIV. Virus infectivity to virion particle ratios were 4- and 10-fold lower in SHIV162p3 M184V and SHIV162p3 K65R, compared to a concurrently generated WT SHIV162p3, respectively. Mucosal transmissibility studies using a repeat low-dose macaque model of rectal and vaginal transmission showed that both mutants were able to efficiently infect macaques only after the dose was increased to adjust for fitness reductions due to K65R and M184V. Our results in limited number of macaques suggest that the reduction in fitness due to M184V and K65R decreases virus transmissibility, and identify in vitro infectivity parameters that associate with mucosal transmissibility.

KW - HIV-1 drug resistance

KW - Mucosal transmissibility

KW - Pre-exposure prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=79952631079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952631079&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2011.01.038

DO - 10.1016/j.virol.2011.01.038

M3 - Article

C2 - 21334708

AN - SCOPUS:79952631079

VL - 412

SP - 435

EP - 440

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -